ArticleMethods in molecular biology (Clifton, N.J.)2026
Discovery of a Polymorphic Gene Fusion via Bottom-Up Chimeric RNA Prediction: Case Study.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gene fusions and their associated chimeric RNAs have historically been recognized for their roles in cancer. However, recent research has increasingly detected chimeric transcripts in normal tissues and noncancerous cell lines. Extensive efforts have begun to annotate genomic structural variation, revealing gene fusions capable of generating chimeric transcripts even in normal tissues. In this study, we present a bottom-up approach targeting population-specific chimeric RNAs, identifying 58 such instances in the GTEx cohort. Among these, notable examples include SUZ12P1-CRLF3, TFG-ADGRG7, and TRPM4-PPFIA3, each associated with ancestry. We present direct genomic evidence for 29 polymorphic chimeric RNAs associated with structural variants, including 13 previously unreported rare variants. Additionally, utilizing data from the All of Us research program alongside a substantial clinical cohort, we characterized the clinical relevance of the SUZ12P1-CRLF3-associated variant. Collectively, our findings highlight the effectiveness of leveraging population-specific chimeric transcripts, exemplified by SUZ12P1-CRLF3, as a method for uncovering otherwise elusive transcribed genomic structural variants.
Indexed as
Identifiers
42400801What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.